Previous Close | 58.19 |
Open | 0.00 |
Bid | 53.00 x 0 |
Ask | 59.19 x 0 |
Day's Range | 0.00 - 0.00 |
52 Week Range | |
Volume | |
Avg. Volume | 9,360 |
Market Cap | 1.659T |
Beta (5Y Monthly) | 0.35 |
PE Ratio (TTM) | 48.40 |
EPS (TTM) | 1.20 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.70 (1.21%) |
Ex-Dividend Date | Feb 14, 2023 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for LILY34.SA
In this article, we will take a look at the 15 most promising long-term stocks according to analysts. To see more such companies, go directly to 5 Most Promising Long-Term Stocks According to Analysts. Investing in the stock market for the long term is perhaps the surest of the ways to expand your wealth. On […]
Key Insights The projected fair value for Eli Lilly is US$388 based on 2 Stage Free Cash Flow to Equity With US$329...
Bernie Sanders recently introduced legislation to make insulin more affordable for people with diabetes. Senator Bernie Sanders, the Senate Health, Education, Labor, and Pensions Committee chairman, and Congresswoman Cori Bush recently introduced legislation to make insulin affordable for more Americans, so no one has to ration their insulin due to financial concerns. In a March 9, 2023 press release, Sen. Sanders said, "There is no reason why Americans should pay the highest prices in the world for insulin -- in some cases, 10 times as much as people in other countries."